Urvi A. Shah, MD, receives award for groundbreaking dietary research in cancer at ASH
Click Here to Manage Email Alerts
Urvi A. Shah, MD, received the David M. Goldenberg Clinical Research Training Institute Award at ASH Annual Meeting and Exposition.
Shah, hematologic oncologist and faculty member in the myeloma division at Memorial Sloan Kettering Cancer Center, was awarded for her groundbreaking research that showed a high-fiber, plant-based diet delayed progression of multiple myeloma among a small cohort of 20 patients.
As Healio previously published, a high-fiber plant-based dietary intervention for 12 weeks followed by 20 weeks of health coaching appeared to delay progression of certain precursor conditions to multiple myeloma among individuals with monoclonal gammopathy of undetermined significance or smoldering myeloma who had BMI of 25 kg/m2 or higher. The intervention also improved biomarkers of the disease, results of the NUTRIVENTION trial showed.
“It is an honor to receive this award, and I am grateful for the recognition being given to dietary research in cancer — an area of unmet need despite patient interest,” Shah told Healio. “I am very excited that our research team has been able to move the needle in this field given precancerous conditions can be anxiety provoking. Low-risk, high-fiber, plant-based dietary interventions can be incredibly empowering for patients through focusing on positive changes that improve overall quality of life, as well as cardiovascular, metabolic, microbiome and immune health, and may delay progression to cancer in a subset of patients.”
Read more about
Click Here to Manage Email Alerts